Efficacy and safety of FTY720 in patients who receive a kidney transplantation.
Phase of Trial: Phase III
Latest Information Update: 01 Nov 2011
At a glance
- Drugs Fingolimod; Immunosuppressants
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Nov 2011 Actual end date (Apr 2006) added as reported by ClinicalTrials.gov.
- 24 Mar 2009 Primary outcomes added as reported by ClinicalTrials.gov.